Valid Ghana · FDA Ghana

VACIT 200

PESIARES

FDA/SD.255-020294 200MG

What it does

Pesiares are a type of medication used to treat certain conditions, although specific details about their class and interactions are not provided.

Commonly used for: vaginal infections, yeast infections

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/SD.255-020294
Registration date
2025-02-24
Expiry date
2029-07-01
Status
Valid
Active ingredient
PESIARES
Dosage form
-
Strength
200MG
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Bliss Gvs Pharma
Country of origin
-
Manufacturer location
102, Hyde Park, Saki Vihar Rd, Ganesh Nagar, Marol, Andheri East, Mumbai, Maharashtra 400072, India

Source: Food and Drugs Authority · fetched 2026-04-18 08:37:52 · updated 2026-09-11 04:00:12

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Pesiares are a type of medication used to treat certain conditions, although specific details about their class and interactions are not provided.

What it treats

  • vaginal infections
  • yeast infections

How it works

Pesiares work by delivering medication directly to the affected area, helping to treat infections and reduce symptoms.

Who it's for

Pesiares are for individuals experiencing vaginal infections or discomfort.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: pesiares

Pesiares, commonly known as suppositories, are a form of medication administered rectally. They are used for local or systemic effects and can contain a variety of active ingredients, including analgesics, anti-inflammatories, and laxatives. The formulation allows for rapid absorption and is beneficial for patients who may have difficulty swallowing oral medications.

Indications

  • Pain management
  • Fever reduction
  • Constipation
  • Nausea and vomiting
  • Local inflammation

Dosage

Children: Refer to BNF for Children for age-appropriate dosing based on the active ingredient.

Adults: Refer to specific product guidelines and BNF for appropriate adult dosing based on the active ingredient.

Mechanism of action

The mechanism of action of pesiares depends on the active ingredient contained within the suppository. Generally, they work by delivering medication directly to the systemic circulation or local tissues, bypassing first-pass metabolism. This can enhance bioavailability and provide quicker therapeutic effects. For instance, if the suppository contains an analgesic, it will bind to specific receptors in the central nervous system to alleviate pain.

Pharmacodynamics

Pesiares exert their effects based on the pharmacological properties of the active substances they contain. For example, analgesics may inhibit cyclooxygenase enzymes, decreasing the production of prostaglandins, which are mediators of pain and inflammation. The local effect may also involve mucosal irritation, leading to increased secretion of mucus or enhanced peristalsis when laxatives are used. The onset of action can vary but is typically faster than oral routes due to the rich vascular supply of the rectal area.

Pharmacokinetics

The pharmacokinetics of pesiares involves absorption, distribution, metabolism, and excretion processes influenced by the formulation and active ingredient. Upon insertion, the suppository dissolves, allowing the active compound to be absorbed through the rectal mucosa into the bloodstream. This route can lead to variable absorption rates depending on factors such as the presence of fecal matter, the formulation of the suppository, and individual patient factors. Metabolism of the active compounds may occur primarily in the liver, with excretion often taking place via the kidneys. The onset of action is generally rapid, often within 15 to 30 minutes.

Pregnancy

Consult healthcare professional before use. Limited data available on safety during pregnancy.

Breast-feeding

Consult healthcare professional before use. Safety during breastfeeding has not been established.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.